An oncolytic adenovirus defective in pRb-binding (dl922–947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine
Cancer Gene Therapy (2011) - Comments
pubmed: 21836633  doi: 10.1038/cgt.2011.45  issn: 1476-5500  issn: 0929-1903 

M Bhattacharyya, J Francis, A Eddouadi, N R Lemoine, G Halldén